Table 1.
the relationship between SNORA7B expression and clinicopathological characteristics in TCGA cohort
| Characteristics | Expression of SNORA7B | P | |
|---|---|---|---|
| Low (n = 541) | High (n = 541) | ||
| Distant metastasis | 0.695 | ||
| M0 | 431 | 466 | |
| M1 | 11 | 10 | |
| Tumor stage (cm) | 0.004* | ||
| ≤ 2 | 160 | 119 | |
| > 2 | 379 | 420 | |
| Age | |||
| Mean | 57.19 ± 12.76 | 59.60 ± 13.57 | 0.003* |
| > 60 | 221 | 262 | 0.012 |
| ≤ 60 | 319 | 278 | |
| HR status | 0.787 | ||
| Positive | 414 | 401 | |
| Negative | 109 | 110 | |
| HER2 | 0.392 | ||
| Positive | 86 | 95 | |
| Negative | 388 | 372 | |
| Menopause status | 0.13 | ||
| Indeterminate | 20 | 13 | |
| Peri | 24 | 16 | |
| Post | 329 | 365 | |
| Pre | 118 | 105 | |
| Lymph node metastasis | 0.045* | ||
| Yes | 262 | 291 | |
| No | 272 | 236 | |
| AJCC stage | 0.058 | ||
| I | 107 | 73 | |
| II | 299 | 314 | |
| III | 116 | 129 | |
| IV | 11 | 10 | |
| Race category | 0.566 | ||
| Asian | 30 | 30 | |
| Black or African American | 102 | 80 | |
| White | 390 | 360 | |
* Statistically significant (p < 0.05)